#socio-demographic data

[neosciencehub]

Study indicates lower rates of death from Alzheimer's Disease among Taxi and Ambulance Drivers

Study indicates lower rates of death from Alzheimer's Disease among Taxi and Ambulance Drivers @neosciencehub #Sciencenews #healthcare #AlzheimersDisease #neosciencehub #Dementia #featured

According to a recent study, occupations requiring a lot of spatial processing, like navigating to a hospital or figuring out a taxi route, may have a reduced death risk from Alzheimer’s disease. Mass General Brigham researchers looked into this possibility by assessing the likelihood of Alzheimer’s disease death across 443 professions using national data on the occupations of deceased…

[upsettingandunfortunateclasshate]

The analysis found that although the proportion of medical students from the lowest socio-economic backgrounds had doubled since 2012, they made up only 5% of entrants in 2021.

In comparison, 75% of medical school entrants were from a higher socio-economic background. Socio-economic status was calculated by using the five-level National Statistics Socio-economic Classification (NS-SEC) groupings of parental occupation.

Applicants from independent schools across the UK were 1.5 times more likely to receive an offer from a medical school compared with students from non-selective state schools and, even after adjusting statistically for their exam grades, socio-economic status and other demographic factors, independent school applications were still more likely to receive an offer.

[m2iconsulting]

Baseline Survey for CSR Program by M2i Consulting: Laying the Foundation for Impactful Initiatives

Corporate Social Responsibility (CSR) programs play a crucial role in driving social and economic development. However, for these programs to be truly effective, they must be based on a clear understanding of the community’s needs, existing challenges, and potential opportunities. This is where a baseline survey for CSR programs becomes essential. M2i Consulting, a trusted name in social impact assessments, specializes in conducting comprehensive baseline surveys to ensure CSR initiatives create meaningful and measurable change.

What is a Baseline Survey for CSR?

A baseline survey is an initial assessment conducted before the implementation of a CSR program. It gathers essential data on socio-economic conditions, demographic details, and key indicators relevant to the initiative. This survey acts as a reference point, allowing organizations to track progress and measure the impact of their CSR activities over time.

Importance of Baseline Surveys in CSR Programs

Informed Decision-Making – A baseline survey provides valuable insights that help companies design targeted and effective CSR interventions.

Resource Optimization – Understanding the real needs of the community ensures that funds and efforts are directed toward the most critical areas.

Impact Measurement – By comparing pre- and post-intervention data, organizations can evaluate the success of their CSR initiatives.

Stakeholder Engagement – A well-executed survey helps in gaining community trust and participation, making CSR programs more sustainable.

Regulatory Compliance – Many governments and regulatory bodies require companies to demonstrate the impact of their CSR initiatives, making baseline surveys a necessity.

How M2i Consulting Conducts Baseline Surveys

At M2i Consulting, we follow a structured and data-driven approach to conducting baseline surveys for CSR programs:

Defining Objectives

We begin by understanding the CSR goals of the organization and identifying key impact areas that need assessment.

Designing the Survey Framework

Our team develops a detailed survey framework, including qualitative and quantitative research methods, to capture relevant data effectively.

Data Collection

Using tools such as field interviews, focus group discussions, and digital surveys, we gather comprehensive data from targeted communities.

Data Analysis & Reporting

We analyze the collected data to identify key insights, trends, and potential challenges that may affect CSR program implementation.

Recommendations & Strategy Development

Based on our findings, we provide actionable recommendations to help organizations structure their CSR programs for maximum impact.

Why Choose M2i Consulting for Baseline Surveys?

Expertise in Social Research – With years of experience in impact assessment, M2i Consulting ensures reliable and accurate data collection.

Custom-Tailored Solutions – We design surveys that align with specific CSR objectives and industry requirements.

Use of Advanced Tools & Methodologies – Our approach integrates modern research techniques, including data analytics and geospatial mapping.

Commitment to Social Impact – We are dedicated to helping organizations create sustainable and transformative CSR initiatives.

Conclusion

A baseline survey for CSR programs is an indispensable step in designing and executing impactful social initiatives. By partnering with M2i Consulting, organizations can ensure that their CSR efforts are evidence-based, goal-oriented, and aligned with the real needs of communities. Our expertise in conducting baseline surveys helps businesses maximize their social impact while fulfilling corporate and regulatory responsibilities.

Are you planning a CSR initiative and need a baseline survey? Get in touch with M2i Consulting today to lay the foundation for a successful and sustainable CSR program!

[trans-koupen-chan]

listen. listen. I need everyone who sees this post to know that the Swedish study that partially looked at crime rates among cis vs. trans people is being WILDLY misinterpreted and used with absolutely zero critical thinking to paint transgender woman as a violent “other.”

the study’s own author has come out and said “The individual […] who is making claims about trans criminality, specifically rape likelihood, is misrepresenting the study findings.”

having looked at both the study and the author’s comments myself, the only similarity between cis men and trans women is the conviction rate by population size, and this similarity is only seen when looking at trans women who had sex reassignment surgery before 1989, when fewer opportunities and resources were available to trans people in Sweden. The study also did not control for socio-economic status which is commonly understood as a MAJOR contributing factor in criminality.

Here’s another quote from the study’s author;

“The difference we observed between the 1989 to 2003 cohort and the control [1973 to 1988] group is that the trans cohort group accessed more mental health care, which is appropriate given the level of ongoing discrimination the group faces. What the data tells us is things are getting measurably better and the issues we found affecting the 1973 to 1988 cohort group likely reflects a time when trans health and physiological care was less effective and social stigma was far worse.”

I will not deny that trans people, both trans women and trans men, sometimes commit or are convicted of crimes. That would be unfactual of me. But I feel as though it’s basic common sense that being convicted of a crime does not automatically make someone a bad or violent or dangerous person — for example, shoplifting food that you otherwise couldn’t afford, or the case of trans woman Tara Wolf, where the judge themself admitted that Wolf was provoked but convicted her of assault anyways. It’s also worth noting that the woman who Wolf had an altercation with approached Wolf and others attempting to film them without consent and admitted to grabbing and kicking Wolf’s partner, highlighting again that there are many cases where a conviction is not a cut-and-dry good/evil situation.

If you believe that the results of this study — or that any one isolated incident — prove that trans women are inherently more violent and criminal than cis woman, I am here to tell you that is incorrect. Even if this paper that looks as though it proves this, which it does not in the eyes of its own author, that would still be insufficient evidence to draw such a broad and sweeping conclusion about an entire demographic group.

Painting any demographic as inherently dangerous and violent is an “othering” tactic that has been used against stigmatized groups and minorities (including radical feminists!) for centuries now. It is not progressive, even if you cite papers and statistics to “prove” it. If you’ve made it this far in the post maybe you should reconsider your stance on this.

(obligatory inclusion: if you believe trans woman are men and trans men are women that is bioessentialist and also not progressive. just to round off the post and make sure we’re clear. limiting people’s choices and basing the way they are treated by society on a few body parts they are born with is inherently antifeminist. no I will not argue about this point.)

[bbmct]

BBMCT: Initiate Medical Research at AIIMS Hospital

Clinical trials play a crucial role in advancing healthcare and providing innovative treatments to patients. One such trusted partner in conducting advanced clinical research is **British Biomedicine Clinical Trials (BBMCT)**, which collaborates with AIIMS Hospital to carry out world-class medical research. As one of India’s premier medical institutions, AIIMS provides a diverse patient base, cutting-edge facilities, and a commitment to ethical research, making it an ideal setting for clinical trials. This blog will explore why BBMCT at AIIMS Hospital is a beacon for excellence in clinical research.

## Esteemed Institution for Clinical Research

AIIMS Hospital, based in New Delhi, is widely regarded as one of the most prestigious medical institutions in India and the world. It is known for its state-of-the-art research capabilities and a longstanding legacy of medical excellence. The hospital is recognized for its commitment to improving healthcare through rigorous clinical research. In partnership with BBMCT, AIIMS is further strengthening its clinical trial programs by offering specialized facilities, experienced medical personnel, and advanced equipment. Together, BBMCT and AIIMS have become a leading force in the world of clinical trials, advancing medical knowledge and patient care.

## Access to Varied Patient Demographics

A unique advantage of conducting clinical trials at AIIMS Hospital is its access to a highly diverse and varied patient demographic. The hospital serves a wide range of patients, representing different socio-economic backgrounds, age groups, and medical conditions. This diversity allows clinical trials to gather valuable data that is more representative of real-world scenarios. For researchers, this diversity enhances the generalizability and applicability of trial results, ensuring that new treatments or drugs are effective across various populations. BBMCT leverages this broad spectrum to enhance the quality of its research.

## Advanced Research Facilities at Disposal

AIIMS Hospital is equipped with some of the most advanced medical and research facilities in the world. From cutting-edge laboratories to specialized treatment rooms, the infrastructure is designed to support a wide array of clinical trials. BBMCT benefits from this extensive research environment, which includes diagnostic technologies, research databases, patient monitoring systems, and more. These facilities ensure that clinical trials are conducted with the highest precision, accuracy, and safety, making AIIMS an ideal partner for research and medical innovation.

## Skilled Investigators Guarantee Quality Results

A crucial aspect of any successful clinical trial is the quality of the investigators. At AIIMS Hospital, BBMCT works with a team of highly skilled, experienced medical professionals and researchers. These investigators are experts in their respective fields, ensuring that every trial is conducted with the utmost care, attention to detail, and scientific rigor. Their expertise guarantees the reliability and credibility of the research findings, which ultimately contribute to the development of safe and effective treatments. With skilled investigators at the helm, BBMCT ensures high-quality clinical trials at AIIMS.

## Dedication to Ethical Research Standards

BBMCT, in collaboration with AIIMS, is committed to maintaining the highest ethical standards in clinical research. Ethical practices are fundamental to the integrity of clinical trials, ensuring that participants are treated with respect and their rights protected. This includes obtaining informed consent, ensuring patient privacy, and providing transparent information regarding the risks and benefits of participating in trials. AIIMS Hospital has a strong ethical framework in place, and BBMCT ensures that all research follows international guidelines, including Good Clinical Practice (GCP) and the Declaration of Helsinki.

## Robust Regulatory Compliance and Assistance

One of the key factors that make BBMCT at AIIMS Hospital a trusted partner in clinical research is the rigorous regulatory compliance. Clinical trials are subject to numerous local and international regulations to ensure the safety and well-being of participants. BBMCT ensures that all clinical trials conducted at AIIMS comply with the Indian Council of Medical Research (ICMR) guidelines and other regulatory bodies. In addition, BBMCT offers assistance with navigating the complex regulatory landscape, ensuring that all approvals are obtained promptly, and trials proceed without unnecessary delays. This ensures trials are conducted ethically and within legal boundaries.

## Streamlined Trial Management and Implementation

Effective management and implementation of clinical trials are essential for achieving reliable results. BBMCT, in partnership with AIIMS, streamlines the entire process — from the initial planning phase to the final data analysis. They provide comprehensive trial management services, including patient recruitment, monitoring, data collection, and regulatory submissions. Their experienced team ensures that trials are conducted on schedule, within budget, and with minimal risk to participants. This efficient trial management system increases the likelihood of successful trial outcomes and accelerates the development of new therapies.

## Proven History of Successful Trials

BBMCT has a proven history of conducting successful clinical trials across multiple therapeutic areas. Their collaboration with AIIMS Hospital has further strengthened this track record, as the hospital provides a rich patient population and exceptional research resources. Over the years, BBMCT has successfully contributed to the development of new medications, treatment protocols, and diagnostic tools. The institution’s commitment to high standards, rigorous protocols, and reliable trial outcomes has earned them a reputation as a leading entity in the field of clinical research.

/media/a6f6f39252e758447bc48d131451b2d9

## FAQs About BBMCT and Clinical Trials at AIIMS Hospital

**1. What types of clinical trials does BBMCT conduct at AIIMS Hospital?**

BBMCT conducts a wide range of clinical trials at AIIMS Hospital, including those focused on oncology, cardiology, neurology, infectious diseases, and rare conditions. They collaborate with various pharmaceutical companies and research organizations to test new treatments, medications, and diagnostic tools.

**2. How does BBMCT ensure patient safety during clinical trials?**

BBMCT prioritizes patient safety by adhering to ethical guidelines, obtaining informed consent, and closely monitoring participants throughout the trial. AIIMS Hospital’s experienced healthcare team ensures that all necessary precautions are taken to minimize risks and protect participants during the research process.

**3. How can patients participate in clinical trials at AIIMS Hospital?**

Patients interested in participating in clinical trials at AIIMS Hospital should first consult their healthcare provider. If eligible, they will be provided with detailed information about the trial and the informed consent process. BBMCT ensures that all participants are fully aware of the trial’s scope, risks, and benefits before enrolling.

**4. What makes BBMCT’s research collaboration with AIIMS Hospital unique?**

The collaboration between BBMCT and AIIMS Hospital is unique because of AIIMS’ world-class medical infrastructure, skilled investigators, and diverse patient population. This combination ensures that clinical trials are conducted with the highest standards of care, precision, and ethical consideration, leading to reliable and impactful research outcomes.

**5. What is the regulatory process for clinical trials at AIIMS Hospital?**

BBMCT ensures that all clinical trials conducted at AIIMS Hospital comply with regulatory guidelines set by bodies such as the ICMR and the Central Drugs Standard Control Organization (CDSCO). The regulatory process includes obtaining approvals from ethical committees, submitting trial protocols for review, and adhering to international standards like Good Clinical Practice (GCP).

## Conclusion

The partnership between BBMCT and AIIMS Hospital represents a powerful collaboration that leverages the strengths of both organizations in the field of clinical research. With AIIMS’ prestigious reputation, advanced facilities, and diverse patient base, and BBMCT’s commitment to ethical, rigorous trial management, this partnership is poised to advance medical science and improve patient outcomes. Whether you are a researcher, healthcare provider, or patient, BBMCT and AIIMS offer a reliable platform for conducting high-quality clinical trials. This collaboration continues to pave the way for the next generation of medical breakthroughs, ensuring that new therapies reach those who need them the most.

Subscribe to BBMCLINICALTRIALS YouTube channel for Research Insights

Be sure to subscribe to the **BBMCLINICALTRIALS YouTube channel** for exclusive access to the latest updates and in-depth insights into British Biomedicine Clinical Trials (BBMCT). Stay informed on cutting-edge research, clinical trial advancements, patient safety protocols, and breakthrough therapies being tested at AIIMS Hospital. Our channel provides expert discussions, industry trends, and detailed videos on the clinical trial process across various therapeutic areas. Whether you’re a healthcare professional, researcher, or simply interested in biomedical innovation, subscribing will keep you at the forefront of clinical research developments. Don’t miss out — join our community today!

[shanetgeisel]

Thursday Check-in

“What questions do you have from the readings that I can answer to help your success in this class? Working with data is new - ask about data. Working with viewable data is likely new - ask about viewable data and conclusions that can be drawn.” #writ318mu #week4 @npfannen

Reading through the notes for this week, I’ve been trying to note and organize the key characteristics to look for while gathering information on the audience. The key elements of analyzing your demographic are:

age

race

gender

socio-economic status

region/geography

After these were listed, you mentioned the point of them not always mattering. I was just wondering if there are any good ways to tell whether or not these characteristics are important in your data?

Happy Thursday!

[transgenderer]

For almost all injecting drug users (IDUs), the first site of injection is the arm. Years after injection, IDUs may shift to using other sites for intravenous (IV) access. Although injection to sites other than the arm is associated with higher risks, literature is limited regarding this behavior. We aimed to determine the prevalence and associated factors of using IV access points other than the arm among a national sample of IDUs in Iran. Data came from the National Drug Dependence Survey, 2007, which had enrolled 863 IDUs with at least one daily injection. Data on socio-demographics, pattern of drug use, and injection-related behaviors were entered into a logistic regression to determine predictors of injection to sites other than the arm. From all participants, 54.8% reported current injection sites in areas other than the arm. The other injection sites were the femoral venous sinus (17.0%), followed by the groin (14.5%) and neck (11.5%). Logistic regression revealed that living alone [odds ratio (OR) = 1.789, 95% confidence interval (CI) = 1.218–2.629], being Sunni (OR = 3.475, 95% CI = 1.775–6.801), having higher family income (OR = 1.002, 95% CI = 1.001–1.003), higher age at first drug use (OR = 1.039, 95% CI = 1.009–1.069), longer injection duration (OR = 1.071, 95% CI = 1.041–1.102), and more injection frequency (OR = 1.255, 95% CI = 1.072–1.471) were associated with higher likelihood of using injection sites other than the arm

Drug Injection to Sites other than Arm: A Study of Iranian Heroin Injectors

im not sure why it draws a distinction between "femoral venous sinus" and "groin", the femoral venous sinus IS the groin

anyway neck seems kind of wise. right to the brain.

[bobapril]

A Mastodon friend is doing a survey of Star Trek fans. I personally enjoyed the questions, and it doesn't seem to be a major privacy risk.

[sidslash918]

Milestone Assignment 2: Methods

Analysis of Socio-Economic Indicators and Adjusted Net National Income per Capita

1. Description of the Sample

The dataset utilized in this analysis is derived from the World Bank, containing a range of socio-economic indicators for multiple countries. Initially, the dataset comprised 248 observations representing various nations. However, to ensure data quality and reliability, any observation with missing values in the selected variables was removed. Following this data-cleaning step, the final sample consisted of 153 observations.

The selection criteria focused on maintaining completeness across all chosen variables, thereby ensuring consistency in statistical analysis. The dataset primarily covers economic, social, and technological indicators, providing a holistic view of national development. While the dataset does not explicitly categorize countries by demographic features such as income groups or regions, it implicitly represents a broad spectrum of economic development levels through variables such as GDP growth, fertility rate, internet access, and foreign direct investment (FDI) inflows.

2. Description of Measures

For this study, the dependent variable is Adjusted Net National Income per Capita (Current US$) (x11_2013). This metric represents the national income adjusted for depreciation and net primary income, offering a refined measure of economic well-being.

The independent variables include a range of socio-economic indicators such as:

Economic indicators: GDP growth, GDP per capita growth, exports, imports, FDI inflows, household final consumption expenditure, private credit bureau coverage.

Demographic indicators: Fertility rate, life expectancy at birth, urban population percentage.

Health and Infrastructure indicators: Health expenditure, out-of-pocket health expenditure, improved sanitation and water facilities, mobile and broadband subscriptions.

Environmental indicators: Forest area percentage, food production index, adjusted savings from CO2 damage.

Social indicators: Proportion of women in parliament, female labor force participation.

To maintain the integrity of quantitative analysis, no variable was transformed into categorical form, nor were composite indices created. All variables remained in their original numerical scale to facilitate bivariate and regression analysis.

3. Description of Analyses

Statistical Methods & Purpose

The study employs a combination of bivariate analysis and Lasso regression:

Bivariate Analysis: This step involves examining the relationships between Adjusted Net National Income per Capita and the selected socio-economic indicators. Correlation coefficients and scatter plots are used to identify the strength and direction of relationships between variables.

Lasso Regression: Given the presence of multiple predictors, Lasso (Least Absolute Shrinkage and Selection Operator) regression is employed to handle potential multicollinearity and improve model interpretability. Lasso regression assists in feature selection by penalizing less relevant variables, leading to a more parsimonious model.

Train-Test Split

To ensure robustness in model evaluation, the dataset is split into:

Training Set (70%): Used for model training.

Test Set (30%): Used for model validation and performance evaluation.

Cross-Validation Approach

A k-fold cross-validation technique is used to fine-tune the Lasso regression model, preventing overfitting and ensuring that the model generalizes well to unseen data.

By implementing this methodological approach, the study aims to identify key socio-economic factors influencing national income levels, providing insights into the determinants of economic prosperity across countries.

[dataanalysis-kagh]

I decided to work with the NESARC data. Because I’m interested to know how much wine is needed for a person to be considered as alcohol dependent.

Sure, an excess of wine consumption will promote the alcohol dependence, but how about people that leave in European countries. They drink wine almost every day and that doesn’t make them alcohol dependent. Therefore, I decided to explore the number or glasses of wine consumed, the type of wine and the familial ascendency.

Research has explored the relationship between wine consumption and alcohol dependence (AD), revealing various insights regarding consumption patterns, demographic influences, and health outcomes.

A significant study by Flensborg-Madsen et al. (2008) found that individuals who primarily consume wine have a lower risk of developing alcohol use disorders (AUD) compared to those who consume beer or distilled spirits. This study analyzed data from a diverse population and indicated that for both genders, drinking more than 35% of total alcohol intake as wine was associated with a notably reduced risk of AUD—0.8 for men and 2.0 for women—compared to higher risks associated with beer consumption [1].

Kerr et al. (2004) examined the influences of age, period, and cohort on beverage-specific alcohol consumption in the United States from 1979 to 2000. The study highlighted that increased educational attainment correlates with higher wine consumption and lower beer consumption among different cohorts. Notably, this research underscores how socio-demographic factors influence drinking behaviors, which may relate to varying risks for alcohol dependence across different age groups [2].

Rosoff et al. (2021) conducted a Mendelian randomization study involving over 780,000 participants to assess the causal effects of educational attainment on alcohol use behaviors, including AD risk. Their findings indicated that higher educational attainment was associated with increased wine consumption while reducing risky drinking behaviors like binge drinking. This suggests an indirect relationship where education may mitigate risks associated with alcohol dependence through altered consumption patterns [3].

The PURE Poland cohort study (2021) examined patterns of alcohol consumption among 2,021 adult participants from urban and rural areas in Poland. The study revealed that 54.6% of participants frequently consumed low-alcohol beverages like wine and beer, with significant differences in drinking behaviors based on gender and education level. Current drinkers showed higher odds of diabetes and cardiovascular diseases compared to abstainers, indicating potential health risks associated with alcohol consumption [4].

The reviewed literature indicates a complex relationship between wine consumption and alcohol dependence influenced by demographic factors such as age, gender, education, and beverage preference. While moderate wine consumption appears to be associated with lower risks of AUD compared to other alcoholic beverages, further research is needed to fully understand these dynamics across different populations. The findings suggest that promoting wine over other alcoholic beverages may be beneficial in reducing the incidence of alcohol-related disorders within specific demographic groups.

Citations:

[1] Flensborg-Madsen T, Knop J, Mortensen EL, Becker U, Makhija N, Sher L, Grønbaek M. Beverage preference and risk of alcohol-use disorders: a Danish prospective cohort study. J Stud Alcohol Drugs. 2008 May;69(3):371-7. doi: 10.15288/jsad.2008.69.371. PMID: 18432379.

[2] Kerr WC, Greenfield TK, Bond J, Ye Y, Rehm J. Age, period and cohort influences on beer, wine and spirits consumption trends in the US National Alcohol Surveys. Addiction. 2004 Sep;99(9):1111-20. doi: 10.1111/j.1360-0443.2004.00820.x. PMID: 15317631.

[3] Rosoff DB, Clarke TK, Adams MJ, McIntosh AM, Davey Smith G, Jung J, Lohoff FW. Educational attainment impacts drinking behaviors and risk for alcohol dependence: results from a two-sample Mendelian randomization study with ~780,000 participants. Mol Psychiatry. 2021 Apr;26(4):1119-1132. doi: 10.1038/s41380-019-0535-9. Epub 2019 Oct 25. PMID: 31649322; PMCID: PMC7182503.

[4] Zatońska K, Psikus P, Basiak-Rasała A, Stępnicka Z, Wołyniec M, Wojtyła A, Szuba A, Połtyn-Zaradna K. Patterns of Alcohol Consumption in the PURE Poland Cohort Study and Their Relationship with Health Problems. Int J Environ Res Public Health. 2021 Apr 15;18(8):4185. doi: 10.3390/ijerph18084185. PMID: 33920940; PMCID: PMC8071311.

[sonarbangla]

The National Skills Development Authority (NSDA)

The National Skills Development Authority (NSDA) is a government agency in Bangladesh, operating under the Chief Adviser's Office. Established in January 2019 under the National Skills Development Authority Act of 2018, the NSDA aims to develop policies and coordinate efforts to create a skilled labor force that meets both national and international market demands.

Key Responsibilities of NSDA:

Policy Formulation: Developing national skills development policies, strategies, and action plans.

Coordination: Aligning various skill development initiatives across ministries, departments, private sectors, and NGOs.

Curriculum Development: Designing and monitoring training curricula to ensure they meet industry standards.

Data Management: Establishing sector-specific skill databases.

Recognition of Prior Learning (RPL): Providing formal acknowledgment of skills acquired through informal means.

Quality Assurance: Enhancing institutional standards, certification processes, and mutual recognition systems.

Industry Collaboration: Forming and supporting Industry Skills Councils to strengthen industry linkages.

Registration: Registering all skill development training institutions.

Funding Recommendations: Advising on the utilization of the National Human Resource Development Fund.

The NSDA operates through three main bodies: the Authority, the Executive Committee, and the Governing Board. The Governing Board is chaired by the Chief Adviser, while the Executive Committee is led by the Principal Secretary to the Chief Adviser.

In 2017, Bangladesh became a member of WorldSkills International, and in 2018, it joined WorldSkills Asia. The country participated in the 45th WorldSkills Competition in Kazan, Russia, in 2019, competing in Pastry & Confectionery and Fashion Technology.

To streamline skill development processes, the NSDA has developed the National Skills Portal (NSP), which offers online registration, training assessments, and certification opportunities. The portal serves as a comprehensive database for training institutions and trainees, facilitating industry access to skilled human resources.

Through these initiatives, the NSDA is committed to transforming Bangladesh's demographic advantage into a demographic dividend by creating a competent and efficient workforce, thereby contributing to the nation's socio-economic development.

[globose0987]

Open Source Speech Recognition Datasets: Opportunities and Challenges

Introduction:

Speech recognition has become a fundamental element of contemporary technology, allowing devices to comprehend and engage with humans in a fluid and intuitive manner. Central to these developments are comprehensive speech recognition datasets, which serve as the basis for training and evaluating machine learning models. Among these, open-source Speech Recognition Dataset are particularly significant, as they enhance accessibility and stimulate innovation across various sectors. Nevertheless, while these datasets offer substantial advantages, they also pose distinct challenges. This article examines both dimensions, highlighting the importance of open-source speech recognition datasets in the current AI environment.

Opportunities

Democratization of Technology : Open-source speech recognition datasets provide advanced AI tools to a wider audience, including independent developers, researchers, and small enterprises. By eliminating the financial constraints associated with acquiring proprietary datasets, innovators are empowered to explore and create state-of-the-art applications such as virtual assistants, real-time transcription services, and language learning platforms.

Diversity in Data : Numerous open-source datasets are collaboratively developed by contributors worldwide. This diversity guarantees the representation of various accents, dialects, and languages, enabling models to perform effectively across different demographics and regions. For example, Mozilla's Common Voice project prioritizes inclusivity by gathering voice samples from speakers of underrepresented languages.

Accelerated Research and Development : Researchers can utilize open-source datasets to swiftly prototype and evaluate new algorithms. The presence of high-quality labeled audio data significantly shortens the time required to initiate projects, allowing teams to concentrate on refining models and expanding the capabilities of speech recognition systems.

Collaborative Enhancement : The open-source framework encourages cooperation among researchers and developers, resulting in ongoing enhancements in the quality and applicability of datasets. Platforms such as GitHub and Kaggle frequently act as central locations where contributors improve datasets, rectify biases, and introduce new features, thereby ensuring that the datasets adapt to the evolving demands of the industry.

Economic Efficiency : For enterprises and organizations, open-source datasets lower the barriers to implementing speech recognition technologies. Businesses can circumvent significant expenses linked to obtaining proprietary datasets, allowing them to allocate resources to other facets of product development.

Challenges

Data Quality and Annotation Precision : A significant challenge associated with open-source datasets is the variability in quality. As these datasets depend on voluntary contributions, the precision of annotations—such as transcription labels—can differ widely. Inaccurately labeled or noisy data can impede model performance, necessitating extensive cleaning and preprocessing efforts.

Bias and Representation Deficiencies : Although open-source datasets are often diverse, they can still reflect biases. Certain languages, accents, or socio-economic groups may be underrepresented, resulting in models that perform optimally for specific users while marginalizing others. Addressing these deficiencies requires intentional efforts in data collection and curation.

Legal and Ethical Issues : Open-source datasets may pose legal challenges, particularly if proper consent is not secured from contributors. Concerns regarding data privacy and intellectual property rights can emerge, especially when datasets contain sensitive or identifiable information.

Scalability and Upkeep : The maintenance and scaling of open-source datasets can be resource-demanding. Ensuring the currency of data, broadening language coverage, and managing storage infrastructure are intricate tasks that often necessitate dedicated teams and financial support.

Limited Domain-Specific Data : While general-purpose datasets are plentiful, domain-specific data—such as medical or legal terminology—is often scarce in the open-source ecosystem. Developing specialized speech recognition systems may require organizations to supplement open datasets with proprietary or custom-collected data.

Prominent Open-Source Speech Recognition Datasets

A number of open-source datasets have emerged as significant resources in the realm of speech recognition. Among these are:

Common Voice by Mozilla: This extensive dataset comprises voice samples in various languages, prioritizing diversity and inclusivity.

LibriSpeech: Originating from audiobooks, this dataset offers a wealth of clean audio-text pairs, making it particularly suitable for training Automatic Speech Recognition (ASR) models.

TED-LIUM: Based on TED Talks, this dataset is extensively utilized in speech-to-text research and includes both audio recordings and their corresponding transcriptions.

SpeechCommands: This dataset is specifically crafted for keyword spotting tasks, containing audio recordings of individual words.

These datasets exemplify the richness and diversity present in the open-source landscape, enabling developers to customize models for particular applications.

Strategies for Addressing Challenges

To fully leverage the capabilities of open-source speech recognition datasets while addressing associated challenges, various strategies can be implemented:

Data Cleaning and Augmentation: Employing preprocessing methods such as noise reduction, normalization, and data augmentation can enhance the quality of datasets and improve model efficacy.

Bias Auditing: Conducting regular evaluations to detect and rectify biases within datasets promotes the development of more equitable AI systems.

Community Engagement: Fostering contributions from underrepresented communities can help bridge representation gaps and enhance the diversity of datasets.

Legal Compliance: Establishing clear consent protocols and adhering to data privacy laws ensures the ethical use of data.

Hybrid Approach: Merging open-source datasets with proprietary or custom-collected data can provide the necessary domain-specific depth for specialized applications.

Conclusion

Open-source speech recognition datasets serve as a transformative element within the AI landscape, promoting accessibility, collaboration, and innovation. Although challenges such as data quality, bias, and maintenance remain, they can be effectively managed through strategic planning and community involvement. By embracing these datasets and collaboratively working towards their enhancement, researchers and developers can unlock new opportunities, leading to speech recognition systems that are more inclusive, precise, and impactful.

As we progress in the age of AI, the significance of open-source speech recognition datasets will continue to expand, profoundly influencing the future of human-computer interaction.

Open source speech recognition datasets are revolutionizing the AI landscape by fostering innovation and accessibility. They offer opportunities for cost-effective research, improved language diversity, and enhanced model accuracy. However, challenges like data quality, privacy concerns, and resource-intensive annotation remain critical. Partnering with Globose Technology Solutions experts ensures you can navigate these complexities effectively, leveraging tailored solutions to maximize the potential of these datasets while addressing their challenges.

[totaldiversityusa]

Diversity Drives Discovery: The Importance of Inclusion in Clinical Research

In recent years, the importance of diversity and inclusion in clinical research has gained significant attention. As the medical field continues to advance, ensuring diversity in clinical trials has become critical for the discovery of more effective, equitable, and personalized healthcare solutions. Research that includes participants from various backgrounds, ethnicities, ages, genders, and health statuses leads to better understanding, broader applicability, and more accurate outcomes.

The Need for Diversity in Clinical Research

Historically, clinical trials have been dominated by a limited demographic, primarily consisting of white, middle-aged males. This lack of diversity has led to gaps in medical knowledge, especially concerning how different populations respond to treatments. For instance, certain medications may have different effects on women, the elderly, or individuals from specific racial or ethnic groups. Without a diverse representation in clinical research, these differences often go unnoticed, leading to suboptimal healthcare solutions for underrepresented populations.

The inclusion of diverse groups in clinical trials ensures that treatments are safer and more effective for everyone. By engaging a variety of participants, researchers can identify variations in how diseases manifest and how different treatments work across demographics. This improves not only the efficacy of drugs but also the safety profiles, leading to better patient outcomes.

Enhancing Clinical Trial Results

Incorporating diverse populations into clinical trials helps to produce more accurate and generalized findings. A study that only includes one specific group may not account for genetic, environmental, or socio-economic differences that affect health outcomes. For example, genetic differences among ethnic groups can influence how individuals metabolize medications, which may result in different side effects or therapeutic responses. Therefore, inclusive clinical research provides insights that are applicable to a wider range of people.

Moreover, as personalized medicine grows, it is vital to understand how treatments work across various genetic profiles. Including diverse participants ensures that discoveries made in clinical trials are not biased or limited to a particular demographic, providing a more comprehensive understanding of treatment effectiveness.

Addressing Health Disparities

Health disparities have long been a concern in global healthcare, with marginalized communities often receiving lower-quality care. By prioritizing diversity in clinical research, the healthcare industry can begin to address these disparities. Research involving diverse populations can uncover unique health risks faced by different groups and provide insights into better prevention and treatment strategies.

For example, certain racial groups may be at higher risk for specific conditions, such as diabetes or hypertension. Clinical trials that include participants from these groups can help identify better management strategies, leading to better care outcomes and a reduction in health inequities.

Building Trust in Medical Research

Another significant aspect of diversity in clinical research is building trust among underrepresented groups. Historically, certain populations have been skeptical of participating in medical research due to past unethical practices or cultural barriers. By ensuring that clinical trials are more inclusive and reflective of the general population, researchers can build trust and foster greater participation, leading to more reliable data and better overall results.

Conclusion

Inclusion in clinical research is not just a moral or ethical consideration; it is a scientific necessity. A diverse representation in clinical trials drives discovery, promotes equity, and ensures that medical advancements benefit everyone. By fostering inclusion, researchers can create a future where healthcare is personalized, effective, and accessible to all. It is time to prioritize diversity in clinical research to unlock breakthroughs that will change the future of medicine.

Email

bizdev@totaldiversity.com

Phone

(214) 855-1222

[bbmct]

BBMCT: Commence Medical Research at AIIMS Hospital

# British Biomedicine Clinical Trials (BBMCT): Your Trusted Partner for Advanced Clinical Research at AIIMS Hospital

Clinical trials are a cornerstone of medical research, helping to shape the future of healthcare. In this regard, **British Biomedicine Clinical Trials (BBMCT)** has emerged as a trusted partner in advancing clinical research at **AIIMS Hospital**, one of India’s leading medical institutions. By providing access to cutting-edge research facilities, diverse patient populations, and a team of experienced professionals, BBMCT is helping transform the landscape of clinical research, ensuring new therapies and treatments are thoroughly tested and validated.

## 1. **Renowned Institution for Clinical Excellence**

AIIMS Hospital, recognized globally for its clinical excellence, plays a pivotal role in advancing medical science and patient care. As a partner of BBMCT, AIIMS provides a unique environment for conducting advanced clinical trials. The hospital’s rich legacy of providing exceptional healthcare services, combined with its state-of-the-art infrastructure, enhances the quality of clinical trials undertaken at its premises. This collaboration ensures that all trials adhere to the highest standards, promoting global confidence in the results produced.

### Why Choose AIIMS for Clinical Trials?

AIIMS is not just a healthcare provider but also a leader in medical research. With decades of experience and a history of groundbreaking discoveries, the hospital is home to some of the best researchers and healthcare professionals in India. Partnering with BBMCT ensures that clinical trials are conducted in an environment of clinical excellence, ensuring that results are reliable, reproducible, and ethical.

## 2. **Access to Diverse Patient Populations**

One of the most significant advantages of conducting clinical trials at AIIMS Hospital with BBMCT is the access to a diverse and extensive patient population. The hospital sees patients from various socio-economic backgrounds, regions, and age groups, providing invaluable data for trials that need a broad and representative sample.

### Diverse Demographics: A Key to Robust Research

Diversity in clinical trial participants is essential for testing the safety and efficacy of treatments across different population segments. BBMCT’s collaboration with AIIMS ensures that trials include a wide range of patient profiles, improving the generalizability of the research findings. The ability to access multiple patient demographics, including those with rare diseases or conditions, adds immense value to the research.

## 3. **State-of-the-Art Research Facilities Available**

AIIMS Hospital boasts some of the most advanced research facilities in India, which are critical for the successful execution of clinical trials. With cutting-edge laboratories, imaging technologies, and clinical equipment, the hospital is well-equipped to handle the most demanding clinical research needs.

### Technology and Infrastructure to Support Advanced Trials

The hospital’s research infrastructure includes specialized labs for molecular biology, clinical pharmacology, microbiology, and other advanced fields of study. These facilities are integrated with the latest technology to ensure that the data generated in clinical trials is accurate, consistent, and aligned with global standards. BBMCT’s access to these facilities plays a crucial role in accelerating clinical trial timelines and improving outcomes.

## 4. **Experienced Investigators Ensure Quality Outcomes**

The success of any clinical trial hinges on the expertise of the investigators leading it. At AIIMS, clinical research is overseen by a team of highly experienced doctors, researchers, and clinical investigators. Their knowledge and proficiency in conducting clinical trials are unparalleled, making them crucial to the success of BBMCT’s studies.

### Expert Oversight: Essential for Reliable Results

BBMCT’s partnership with AIIMS allows for the recruitment of top-tier investigators who are familiar with the latest research protocols and methodologies. These experts ensure that all trials meet the highest scientific and ethical standards. Furthermore, the involvement of experienced professionals increases the likelihood of producing reliable and impactful results, contributing to the advancement of medical science.

## 5. **Commitment to Ethical Research Practices**

Ethical considerations are central to the conduct of clinical trials, and both BBMCT and AIIMS are firmly committed to maintaining the highest ethical standards. The protection of patient rights, ensuring informed consent, and upholding confidentiality are non-negotiable aspects of their research approach.

### Upholding the Integrity of Clinical Trials

Clinical trials at AIIMS are conducted in strict adherence to ethical guidelines, such as Good Clinical Practice (GCP) and international research standards. The research ethics committee at AIIMS ensures that every trial proposal undergoes rigorous ethical review before it begins. This commitment to ethical research practices ensures that patients’ well-being is prioritized throughout the trial process.

## 6. **Strong Regulatory Compliance and Support**

Regulatory compliance is a critical element in the successful execution of clinical trials. BBMCT, in collaboration with AIIMS, ensures that all clinical trials comply with national and international regulatory standards. This includes obtaining approvals from regulatory bodies like the **Drugs Controller General of India (DCGI)** and the **Institutional Ethics Committee (IEC)**.

### Navigating the Regulatory Landscape with Ease

Both BBMCT and AIIMS have a deep understanding of regulatory frameworks, which enables seamless trial initiation and execution. Their partnership ensures that all clinical trials meet the necessary legal and ethical requirements, mitigating risks and enhancing the credibility of the research. The regulatory support provided by AIIMS ensures that trials are conducted in full compliance with global standards, making them more widely accepted by regulatory agencies.

## 7. **Efficient Trial Management and Execution**

BBMCT’s expertise in clinical trial management, combined with AIIMS Hospital’s resources, ensures the efficient execution of clinical research studies. The seamless coordination between both entities streamlines all aspects of the trial process, from patient recruitment to data analysis and reporting.

### Streamlining Clinical Trials from Start to Finish

BBMCT’s structured approach to trial management involves detailed planning, implementation, and monitoring, ensuring that all phases of a clinical trial are executed efficiently. This collaborative process reduces delays, optimizes resource allocation, and minimizes costs. With experienced teams handling all administrative, regulatory, and clinical tasks, trials are completed on time and within budget, ensuring that research progresses without unnecessary setbacks.

## 8. **Proven Track Record of Success**

BBMCT’s longstanding track record in conducting successful clinical trials is a testament to the expertise, professionalism, and commitment they bring to each study. This proven success, in collaboration with AIIMS Hospital, ensures that clinical research is not only efficient but also effective.

### Demonstrated Success in Clinical Research

The success of BBMCT’s clinical trials can be seen in the numerous therapies, drugs, and treatments that have passed through the rigorous testing phases at AIIMS. The partnership between AIIMS and BBMCT has led to the successful completion of numerous trials, resulting in innovations that have contributed significantly to the medical field. With this experience, both parties are well-positioned to handle the complexities of modern clinical research.

/media/da12b76900a98da20ed4893e9c3dd44b

 — -

### FAQs

**1. What is the role of BBMCT in clinical trials at AIIMS Hospital?**

BBMCT plays a crucial role as a partner in managing and executing clinical trials at AIIMS Hospital. They ensure that the trials are well-designed, properly executed, and comply with international standards. Their expertise in trial management and execution, combined with AIIMS’ state-of-the-art facilities, ensures high-quality research outcomes.

**2. How does BBMCT ensure ethical standards in clinical trials?**

BBMCT follows rigorous ethical guidelines in collaboration with AIIMS, ensuring that all clinical trials are conducted in accordance with Good Clinical Practice (GCP) and international ethical standards. This includes obtaining informed consent from patients, ensuring confidentiality, and maintaining patient safety throughout the trial process.

**3. What are the advantages of conducting clinical trials at AIIMS Hospital?**

AIIMS offers state-of-the-art research facilities, a diverse patient population, and a team of experienced investigators. This ensures that clinical trials are executed efficiently and that the results are reliable, making it an ideal location for conducting advanced medical research.

**4. How does BBMCT manage the regulatory aspects of clinical trials?**

BBMCT ensures that all clinical trials at AIIMS comply with national and international regulatory standards. They handle the necessary regulatory approvals, liaising with bodies like the Drugs Controller General of India (DCGI) and the Institutional Ethics Committee (IEC) to ensure compliance at every stage of the trial.

**5. What is the success rate of clinical trials conducted by BBMCT at AIIMS?**

BBMCT has a proven track record of successfully completing numerous clinical trials at AIIMS. Their experience in trial management, combined with AIIMS’ world-class facilities and expertise, contributes to the high success rate of the trials conducted, leading to meaningful advancements in medical research.

 — -

### Conclusion

In conclusion, **British Biomedicine Clinical Trials (BBMCT)**, in partnership with **AIIMS Hospital**, offers a unique and unparalleled opportunity for advanced clinical research. With access to state-of-the-art facilities, a diverse patient population, and a team of experienced investigators, BBMCT ensures that clinical trials are conducted with the highest standards of quality, ethics, and regulatory compliance. Their proven track record of success further solidifies their role as a leader in clinical research, providing new treatments and therapies that have the potential to transform the healthcare landscape. For researchers and healthcare professionals seeking a trusted partner for clinical trials, BBMCT at AIIMS Hospital is the ideal choice to drive medical innovation.

Subscribe to BBMCLINICALTRIALS YouTube channel for Research Insights

Be sure to subscribe to the **BBMCLINICALTRIALS YouTube channel** for exclusive access to the latest updates and in-depth insights into British Biomedicine Clinical Trials (BBMCT). Stay informed on cutting-edge research, clinical trial advancements, patient safety protocols, and breakthrough therapies being tested at AIIMS Hospital. Our channel provides expert discussions, industry trends, and detailed videos on the clinical trial process across various therapeutic areas. Whether you’re a healthcare professional, researcher, or simply interested in biomedical innovation, subscribing will keep you at the forefront of clinical research developments. Don’t miss out — join our community today!

[commwiserconsultants]

AI in PR: Revolutionizing the landscape of Public Relations

The advent of artificial intelligence (AI) has permeated every aspect of our lives, and the field of public relations (PR) is no exception. PR, which involves exchanging information between organizations, individuals, and the public, has witnessed a transformation due to the influence of AI. AI, an umbrella term encompassing technologies such as data analysis, natural language processing, and automation, can potentially redefine how PR professionals approach communication and marketing.

AI’s impact on PR extends beyond our personal lives and has reshaped our professional landscape. PR practitioners must understand how AI influences communication strategies to leverage its potential fully. Integrating AI technologies presents opportunities for enhanced PR practices, including data-driven decision-making, improved brand management, and targeted audience engagement.

PR practitioners may use AI-powered tools and systems to collect and analyze massive volumes of data, find new insights, and offer targeted and personalized messages. These developments enable public relations professionals to make more informed judgments, enhance campaign plans, and build deeper relationships with their target audiences.

Read More : Law firm

The evolution of PR-

The growth of public relations (PR) in the Indian market has been intriguing, reflecting socio-cultural upheavals and technical improvements in the country. In the early 20th century, public relations (PR) evolved in India as a weapon for nationalistic movements and political propaganda. It became a strategic communication discipline after independence, concentrating on nation-building and industrial prosperity.

With globalization and liberalization, public relations in India adopted foreign practices and broadened its scope to include corporate communication, brand management, and crisis management. The growth of digital media, social networking, and influencer marketing in the 21st century has revolutionized the PR environment, enabling customized campaigns, real-time interaction, and data-driven tactics. Today, Indian public relations practitioners traverse a complex ecology, combining traditional values with modern ways to communicate with various audiences in a quickly changing environment.

AI and PR – A Powerful Synergy

AI and PR have formed a powerful synergy, revolutionizing communication and engagement in the Indian market. AI technologies like natural language processing and data analytics enable PR professionals to gain valuable insights, streamline processes, and deliver targeted messaging. AI-powered media monitoring tools track mentions, analyze sentiment, and provide real-time data, enhancing campaign effectiveness.

Additionally, AI-driven recommendation systems help identifyrelevant influencers and optimize media strategies. Recent examples include personalized chatbots handling customer queries, AI algorithms curating news feeds, and sentiment analysis tools monitoring social media conversations. The collaboration of AI and PR empowers organizations to make data-driven decisions, build stronger relationships, and achieve unparalleled success in the ever-evolving landscape.

Also Read : Mental harassment Act

Advantages of AI in PR-

Efficient Media Monitoring: AI-powered tools automate media monitoring, saving PR professionals time and effort. It particularly benefits the Indian market with its diverse media landscape and multiple languages.

Data Analysis and Insights: AI algorithms analyze vast amounts of data quickly, providing valuable insights for data-driven decision-making in PR campaigns and strategies and helping organizations navigate the Indian market effectively.

Personalized Outreach: AI-driven recommendation systems identify relevant influencers and media outlets, enabling personalized outreach and targeted messaging to specific Indian demographics and cultural preferences.

Crisis Management: AI-powered sentiment analysis tools monitor public sentiment in real-time, assisting PR teams in effective crisis management and reputation protection in the dynamic Indian market.

Enhanced Campaign Effectiveness: By leveraging AI, PR professionals optimize media strategies, identify trending topics, and stay ahead of the competition, resulting in more effective and impactful campaigns in the Indian context.

Real-time Engagement: AI-powered chatbots and automated systems facilitate real-time engagement, addressing customer queries and providing personalized experiences on digital platforms, enhancing customer engagement in the Indian market.

Cost and Time Efficiency: AI streamlines PR processes, reducing manual effort and saving time and costs associated with media monitoring, analysis, and campaign management, which is especially advantageous in the Indian market’s scale and complexity.

Digital Transformation: AI empowers Indian PR professionals to embrace digital transformation, leveraging social media platforms, influencer marketing, and data analytics to maximize reach, engagement, and campaign impact in the digital era, keeping up with the evolving Indian market trends.

Challenges and Ethical Considerations-

Integrating AI in PR in India brings unique challenges and ethical considerations. Data privacy and security are critical concerns, as AI relies on large amounts of data. Addressing cultural sensitivities and ensuring inclusivity in communication strategies is crucial in a diverse nation like India. Transparency in AI algorithms is essential to maintain trust and avoid potential biases. Ethical considerations include responsible use of AI, protecting user privacy, and upholding ethical standards while leveraging AI’s benefits. Striking a balance between innovation and ethical practices is paramount for Indian PR professionals to navigate the challenges and foster public trust in the AI-driven PR landscape.

Future of AI-

The future of AI in India’s public relations sector has enormous promise for dramatic breakthroughs. AI will continue to alter and transform public relations practices by providing improved data analytics, personalized communication tactics, and real-time interaction. Natural language processing, machine learning, and chatbots are AI-powered technology that will expediteoperations, optimize media campaigns, and offer tailored messaging. AI integration will help public relations professionals navigate the changing media landscape, make data-driven choices, and build closer relationships with their target audiences. As AI advances, the future of public relations in India will be defined by the creativity, efficiency, and strategic communication driven by AI technology.

Way Forward-

Integrating AI into the Indian PR market has brought significant advancements and opportunities. AI technologies offer improved data analysis, personalized outreach, crisis management, and cost and time efficiency. However, addressing challenges such as data privacy, cultural sensitivities, and biases is crucial while upholding ethical standards.

Striking a balance between leveraging AI’s benefits and maintaining ethical practices is essential for PR professionals to navigate the evolving landscape successfully. By embracing AI responsibly and harnessing its power, Indian PR practitioners can drive effective communication strategies, enhance audience engagement, and achieve remarkable success in the dynamic and competitive PR market.

Source : https://commwiser.com/ai-in-pr-revolutionizing-the-landscape-of-public-relations-2/